Work

Burden, characteristics and outcomes of COPD patients experiencing moderate or severe exacerbations on triple therapy (ANTLIA NOVELTY)

Year: 2025

Type: conference-abstract

DOI: 10.1183/13993003.congress-2025.pa311

Authors: Hana Müllerová, Xiaomeng Ma, Helen Reddel, Rosa Faner, Maarten Van Den Berge, Stephanie Christenson, Henrik Watz, João André Alves, Amit Parulekar, Sherri So, Alberto Papi

Institutions: AstraZeneca (United Kingdom), AstraZeneca (Canada), The University of Sydney, Woolcock Institute of Medical Research, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, University Medical Center Groningen, University of Groningen, University of California, San Francisco, German Center for Lung Research, LungenClinic Grosshansdorf, AstraZeneca (Sweden), AstraZeneca (United States), University of Ferrara

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416638170

Cites:

Cited by:

Related to: